IKT - Inhibikase Therapeutics Inc
IEX Last Trade
1.39
0.003 0.252%
Share volume: 3,098
Last Updated: Fri 30 Aug 2024 08:39:54 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.39
0.00
0.25%
Summary score
24%
Profitability
25%
Dept financing
6%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-24.16%
Return on assets
-19.44%
Return on sales
-36732160.16%
Return on invested capital
147.24%
Total debt ratio
15.89%
Debt ratio change over timeo
-0.87%
Current Ratio
9.2%
Quick Ratio
9.2%
Cash Position Ratio
8.72%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-41.74%
Return on assets
-32%
Return on sales
-146789307.15%
Return on invested capital
171.09%
Total debt ratio
23%
Debt ratio change over timeo
-0.77%
Current Ratio
5.28%
Quick Ratio
5.28%
Cash Position Ratio
4.99%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-68.61%
Return on assets
-43.21%
Return on sales
0%
Return on invested capital
117.04%
Total debt ratio
38.77%
Debt ratio change over time
-0.47%
Current Ratio
2.55%
Quick Ratio
2.55%
Cash Position Ratio
2.3%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-120.35%
Return on assets
-115.68%
Return on sales
-31384762.59%
Return on invested capital
5.4%
Total debt ratio
-86.83%
Debt ratio change over time
-0.87%
Current Ratio
5.47%
Quick Ratio
5.47%
Cash Position Ratio
5.14%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IKT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -24.16% | 13.79% | 34.47% | 7.43% |
| Return on assets | -19.44% | 2.76% | 3.15% | 5.62% |
| Return on sales | -36732160.16% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 147.24% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 60% | 59% |
| Total debt ratio | 15.89% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.87% | 308.97% | -6.99% | 1.18% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 5.28% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 5.28% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 4.99% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 5% | 12% | 28% |
| Short-term ratios | IKT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -41.74% | 13.77% | 13.25% | 3.8% |
| Return on assets | -32% | 2.43% | 1.89% | 3.09% |
| Return on sales | -146789307.15% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 171.09% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 58% |
| Total debt ratio | 23% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.77% | 46.38% | -72.08% | 1.51% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 5.28% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 5.28% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 4.99% | 0.36% | 1.28% | 2.93% |
| Liquididy | 74% | 10% | 25% | 62% |